{"id":1528,"date":"2023-12-13T09:45:33","date_gmt":"2023-12-13T09:45:33","guid":{"rendered":"https:\/\/gebro.es\/business-development-e-innovacion\/"},"modified":"2026-02-25T13:43:26","modified_gmt":"2026-02-25T13:43:26","slug":"business-development-i-innovacio","status":"publish","type":"page","link":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/","title":{"rendered":"Business Development &amp; innovaci\u00f3"},"content":{"rendered":"<section class=\"relative min-h-screen flex items-end \">\n  <div class=\"absolute w-full h-full\">\n    <img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"1440\" src=\"https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-scaled.jpg\" class=\"w-full h-full object-cover\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-scaled.jpg 2560w, https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-300x169.jpg 300w, https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-1024x576.jpg 1024w, https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-768x432.jpg 768w, https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-1536x864.jpg 1536w, https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-2048x1152.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/>\n  <\/div>\n    <div class=\"absolute w-full h-full bg-gradient-to-t from-blue-900 to-transparent opacity-30\"><\/div>\n    <div class=\"w-full relative z-30 py-20 lg:mt-40\">\n    <div class=\"container flex flex-col gap-y-6 justify-end items-end\">\n      <div class=\"w-full\">\n       <h1 class=\"font-bold text-gray-100 text-5xl leading-none md:text-7xl lg:text-8xl 2xl:text-9xl  lg:w-2\/3 \">Business Development &#038; innovaci\u00f3 <\/h1>\n      <\/div>\n            <hr class=\"border-gray-100 border-t-2 w-full\">\n      <div class=\"text-gray-100 text-lg lg:text-xl 2xl:text-2xl lg:w-2\/5 \">\n        <p>Licensing in &#038; out i estrat\u00e8gia de col\u00b7laboraci\u00f3 o partnering<\/p>\n\n      <\/div>\n          <\/div>\n  <\/div>\n<\/section>\n\n\n<section class=\"container py-6  \">\n    <div id=\"breadcrumbs\" class=\"breadcrumbs\"><span><span><a href=\"https:\/\/gebro.es\/ca\/\"><i class=\"icon-home\"><\/i><\/a><\/span><\/span><\/div>\n<\/section>\n\n\n<section class=\"container grid grid-cols-12 gap-x-8 gap-y-10 py-6 lg:py-10 overflow-visible relative\">\n  <div class=\"col-span-full lg:col-span-5 flex flex-col gap-6 lg:gap-10 \">\n    <h2 class=\"text-4xl lg:text-5xl 2xl:text-6xl font-bold\">Licensing-in<\/h2>     <p class=\"text-lg lg:text-xl 2xl:text-2xl font-bold\">Licensing-In de Laboratorios Gebro Pharma: l\u2019elecci\u00f3 d&#8217;un player local per a acords regionals<\/p>   <\/div>\n    <div class=\"col-span-full lg:col-span-5 lg:col-end-13 \">\n    <div class=\"text-md lg:text-lg 2xl:text-xl\">\n      <p>El model de negoci de Gebro Pharma es basa en la construcci\u00f3 de marques fortes a trav\u00e9s de la promoci\u00f3 activa i l&#8217;atenci\u00f3 de qualitat a especialistes. Es complementa amb una alta inversi\u00f3 en activitats cient\u00edfiques i m\u00e0rqueting de valor afegit.<\/p>\n<p>Gebro Pharma, el partner m\u00e9s competitiu de comercialitzaci\u00f3 de la seva classe, se centra en el licensing-in, \u00e9s a dir, en l&#8217;adquisici\u00f3 d&#8217;actius i registres farmac\u00e8utics o llic\u00e8ncies, aix\u00ed com en el desenvolupament de productes sanitaris especialitzats i innovadors per a la salut. Compromesos amb la millora de la qualitat de vida de les persones, busquem activament productes de prescripci\u00f3 en les \u00e0rees seg\u00fcents:<\/p>\n\n    <\/div>\n  <\/div>\n    <div class=\"col-span-full lg:col-span-6 relative overflow-scroll hide-scroll max-sm:-mr-4 max-sm:pr-4\">\n    <table class=\"simpletable\">\n      <thead class=\"bg-cyan-500 bg-opacity-20\">\n        <tr>\n          <th><\/th>\n          <th>SPECIALTY<\/th>\n          <th>HOSPITAL<\/th>\n          <th>OTC<\/th>\n        <\/tr>\n      <\/thead>\n      <tbody>\n                <tr>\n          <td class=\"bg-cyan-500 bg-opacity-20\">Austria<\/td>\n          <td>\n            <ul>\n                                          <li>Dolor<\/li>\n                            <li>Autoimmunes\t<\/li>\n                            <li>Gastrointestinal<\/li>\n                            <li>SNC<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                                          <li>Anest\u00e8sics<\/li>\n                            <li>Oncologia<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                                          <li>Dolor<\/li>\n                            <li>Dermatologia<\/li>\n                            <li>Tos i refredat<\/li>\n                                        <\/ul>\n          <\/td>\n        <\/tr>\n                <tr>\n          <td class=\"bg-cyan-500 bg-opacity-20\">Espa\u00f1a<\/td>\n          <td>\n            <ul>\n                                          <li>Dolor<\/li>\n                            <li>Autoimmunes<\/li>\n                            <li>Uroginecologia<\/li>\n                            <li>Respiratori<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                                          <li>Dolor<\/li>\n                            <li>Neurocirugia<\/li>\n                            <li>Hematooncologia<\/li>\n                            <li>Uroginecologia<\/li>\n                            <li>Malalties orfes<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                          <\/ul>\n          <\/td>\n        <\/tr>\n                <tr>\n          <td class=\"bg-cyan-500 bg-opacity-20\">Suiza<\/td>\n          <td>\n            <ul>\n                                          <li>Dolor<\/li>\n                            <li>Autoimmunes<\/li>\n                            <li>Dermatologia<\/li>\n                            <li>Tos i refredat<\/li>\n                            <li>Fitoter\u00e0pia<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                                          <li>Malalties orfes<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                                          <li>Dolor<\/li>\n                            <li>Dermatologia<\/li>\n                            <li>Tos i refredat<\/li>\n                                        <\/ul>\n          <\/td>\n        <\/tr>\n        \n      <\/tbody>\n    <\/table>\n  <\/div>\n    <div class=\"col-span-full lg:col-span-6 \">\n    <img loading=\"lazy\" decoding=\"async\" width=\"690\" height=\"704\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa_business.png\" class=\"w-full\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa_business.png 690w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa_business-294x300.png 294w\" sizes=\"auto, (max-width: 690px) 100vw, 690px\" \/>\n  <\/div>\n  <\/section>\n\n\n<section class=\"container py-6 lg:py-10 \">\n          <div class=\"grid grid-cols-12 gap-x-8 gap-y-10 items-center pb-6\">\n            <div class=\"col-span-full lg:col-span-6 \">\n              <img loading=\"lazy\" decoding=\"async\" width=\"592\" height=\"605\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/business_1.png\" class=\"w-full rounded-xl\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/business_1.png 592w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/business_1-294x300.png 294w\" sizes=\"auto, (max-width: 592px) 100vw, 592px\" \/>\n            <\/div>\n            <div class=\"col-span-full lg:col-span-5 lg:col-end-13 flex flex-col gap-y-6 lg:gap-y-10\">\n              <h3 class=\"text-lg lg:text-xl 2xl:text-2xl font-bold\">Altres mercats europeus, inclosos els dels nostres partners a termini llarg<\/h3>\n              <div class=\"text-md lg:text-lg 2xl:text-xl rich-text\">\n                Gebro Pharma ofereix un profund coneixement del mercat en les seves \u00e0rees d&#8217;inter\u00e8s terap\u00e8utic i una gran flexibilitat tant en el tracte amb els socis com en el model de col\u00b7laboraci\u00f3. Des del departament de Business Development &#038; Innovation, totes les persones dins de l&#8217;organitzaci\u00f3 estan altament compromeses a garantir que els nous projectes aconsegueixin el seu m\u00e0xim potencial.\n              <\/div>\n            <\/div>\n          <\/div>\n        <\/section>\n            \n            <section class=\"container py-6 lg:py-10 \">\n          <div class=\"grid grid-cols-12 gap-6 items-center\">\n            <div class=\"col-span-full lg:col-span-5  flex flex-col gap-y-6 lg:gap-y-10\">\n              <h3 class=\"text-lg lg:text-xl 2xl:text-2xl font-bold\">El Grupo Gebro Holding<\/h3>\n              <div class=\"text-md lg:text-lg 2xl:text-xl\">\n                <p>Som una empresa privada familiar orientada a col\u00b7laborar amb una perspectiva de marca. A nivell internacional oferim:<\/p>\n<ul>\n<li>Productes propis per ser llicenciats (licensing-out)<\/li>\n<li>Estructures pr\u00f2pies per als productes que es llicencien en els mercats establerts del grup Gebro (\u00c0ustria, Espanya i Su\u00efssa), aix\u00ed com per als mercats de la nostra xarxa de partners.<\/li>\n<\/ul>\n\n              <\/div>\n            <\/div>\n                          <div class=\"col-span-full flex flex-col gap-y-2 border-t border-gray-300 py-6\">\n                <p class=\"text-m\">Descobrir m\u00e9s a<\/p>\n                <a href=https:\/\/gebro.com\n                  class=\"text-lg font-bold text-cyan-600 underline underline-offset-2 hover:text-cyan-700\">https:\/\/gebro.com<\/a>\n              <\/div>\n                      <\/div>\n                      <div class=\"w-full pb-10 lg:pb-20\">\n              <img loading=\"lazy\" decoding=\"async\" width=\"1216\" height=\"703\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa-business_gran.png\" class=\"w-full\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa-business_gran.png 1216w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa-business_gran-300x173.png 300w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa-business_gran-1024x592.png 1024w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa-business_gran-768x444.png 768w\" sizes=\"auto, (max-width: 1216px) 100vw, 1216px\" \/>\n            <\/div>\n                  <\/section>\n            \n            <section class=\"container py-6 lg:py-10 \">\n          <div class=\"w-full flex flex-col gap-6\">\n                          <p class=\"font-bold text-xl max-w-lg\">La nostra proposta de valor es basa en aquests quatre pilars:<\/p>\n                        <div class=\"grid grid-cols-2 lg:grid-cols-4 gap-4 lg:gap-8\">\n                              <div\n                  class=\"relative aspect-3\/5 bg-cyan-500 bg-opacity-20 border border-cyan-500 rounded-lg px-3 py-4 lg:p-4 \">\n                  <p class=\"text-md lg:text-lg 2xl:text-xl\">Partnership orientat a la consecuci\u00f3 \u00e0gil d\u2019acords<\/p>\n                  <img decoding=\"async\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/hub.svg\" class=\"absolute bottom-0 right-0 w-32 lg:w-52 h-auto\" alt=\"\" \/>\n                <\/div>\n                              <div\n                  class=\"relative aspect-3\/5 bg-cyan-500 bg-opacity-20 border border-cyan-500 rounded-lg px-3 py-4 lg:p-4 \">\n                  <p class=\"text-md lg:text-lg 2xl:text-xl\">S\u00f2lid coneixement en Assumptes Regulatoris<\/p>\n                  <img decoding=\"async\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/trending_up.svg\" class=\"absolute bottom-0 right-0 w-32 lg:w-52 h-auto\" alt=\"\" \/>\n                <\/div>\n                              <div\n                  class=\"relative aspect-3\/5 bg-cyan-500 bg-opacity-20 border border-cyan-500 rounded-lg px-3 py-4 lg:p-4 \">\n                  <p class=\"text-md lg:text-lg 2xl:text-xl\">Excel\u00b7l\u00e8ncia del Model comercial i la For\u00e7a de Vendes<\/p>\n                  <img decoding=\"async\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/know-how.svg\" class=\"absolute bottom-0 right-0 w-32 lg:w-52 h-auto\" alt=\"\" \/>\n                <\/div>\n                              <div\n                  class=\"relative aspect-3\/5 bg-cyan-500 bg-opacity-20 border border-cyan-500 rounded-lg px-3 py-4 lg:p-4 \">\n                  <p class=\"text-md lg:text-lg 2xl:text-xl\">Comprom\u00eds amb tots els productes<\/p>\n                  <img decoding=\"async\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/vacunas.svg\" class=\"absolute bottom-0 right-0 w-32 lg:w-52 h-auto\" alt=\"\" \/>\n                <\/div>\n                          <\/div>\n          <\/div>\n        <\/section>\n            \n            <section class=\"container grid grid-cols-12 gap-x-8 gap-y-6 py-6 lg:py-20 \">\n                      <div class=\"col-span-full\">\n              <h2 class=\"text-4xl lg:text-5xl 2xl:text-6xl font-bold\">Licensing-out<\/h2>\n            <\/div>\n                    <div class=\"col-span-full lg:col-span-5 flex flex-col gap-6 lg:gap-14 \">\n                          <div class=\"flex flex-col gap-6 text-md lg:text-lg 2xl:text-xl\">\n                <p>El Grup Gebro Holding comercialitza les seves pr\u00f2pies marques i tamb\u00e9 estableix acords amb tercers per a la seva comercialitzaci\u00f3.<\/p>\n<p>Posem els pacients i els professionals de la salut al centre. Ens apassiona crear els nostres propis projectes d&#8217;innovaci\u00f3 associant-nos amb reconeguts grups de recerca p\u00fablics i privats, i amb institucions nacionals del m\u00e9s alt nivell.<\/p>\n\n              <\/div>\n                                      <div class=\"flex flex-col gap-6 \">\n\n                <div class=\"flex items-center gap-2\">\n                  <input type=\"checkbox\" name=\"healthworkerLeft\" id=\"healthworkerLeft\" class=\"w-4 h-4 healthcare-actioner\">\n                  <label for=\"healthworkerLeft\">\n                    <div class=\"checkbox\"><\/div>\n                    S\u00f3c treballador sanitari\n                  <\/label>\n                <\/div>\n                <div class=\"hidden\">\n                  <a href=https:\/\/gebro.es\/ca\/business-development-e-innovacion\/licensing-out\/ class=\"flex flex-row gap-4 items-center text-base lg:text-md 2xl:text-lg font-bold group \"\n                    target=\"\">\n                    <div class=\"transform translate-x-0 group-hover:translate-x-2 transition duration-500 ease-in-out bg-opacity-20 border border-opacity-20 rounded-full w-fit h-auto p-1 lg:p-2  bg-cyan-500 border-cyan-500 text-cyan-500\">\n  <svg class=\"w-6 h-auto\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" fill=\"none\">\n<path fill=\"currentColor\" d=\"M16.627 12.75H4.5v-1.5h12.127L10.93 5.554 12 4.5l7.5 7.5-7.5 7.5-1.07-1.054 5.697-5.696Z\"\/>\n<\/svg>\n<\/div>\n                    Llegir-ne m\u00e9s\n                  <\/a>\n                <\/div>\n\n              <\/div>\n                      <\/div>\n          <div class=\"col-span-full lg:col-span-5 lg:col-end-13 flex flex-col divide-y divide-gray-300\">\n                          <div class=\"text-xl pb-6\">\n                <p>A la nostra <a href=\"https:\/\/gebro.com\" target=\"_blank\" rel=\"noopener\">seu central a \u00c0ustria<\/a> oferim serveis complets de desenvolupament de producte, des de la idea fins al medicament o producte acabat.<\/p>\n<p>Disposem de:<\/p>\n<ul>\n<li>Un laboratori gal\u00e8nic equipat amb tecnologia de punta.<\/li>\n<li>Desenvolupament, escalat i formulaci\u00f3 de solucions farmac\u00e8utiques s\u00f2lides, l\u00edquides i semis\u00f2lides.<\/li>\n<li>Desenvolupament de receptes, incloent la producci\u00f3 de mostres de pre-estabilitat.<\/li>\n<li>Escalat i suport a la transfer\u00e8ncia del producte a les nostres instal\u00b7lacions de producci\u00f3 fins a la validaci\u00f3 del proc\u00e9s.<\/li>\n<li>Desenvolupament i validaci\u00f3 de m\u00e8todes anal\u00edtics comuns.<\/li>\n<li>An\u00e0lisi qu\u00edmic-f\u00edsic de s\u00e8ries d&#8217;assaigs, mostres de pre-estabilitat i estabilitat ICH.<\/li>\n<\/ul>\n\n              <\/div>\n                                    <div class=\"col-span-full flex flex-col gap-y-2 border-t border-gray-300 py-6\">\n              <p class=\"text-m\">Descobrir m\u00e9s a<\/p>\n              <a href=\"https:\/\/gebro.at\/\"\n                class=\"text-lg font-bold text-cyan-600 underline underline-offset-2 hover:text-cyan-700\">https:\/\/gebro.at\/<\/a>\n            <\/div>\n          <\/div>\n        <\/section>\n            \n                      <section class=\"container grid grid-cols-12 gap-x-8 gap-y-20 py-6 lg:py-20 \">\n            <div class=\"col-span-full lg:col-span-6 flex flex-col gap-6\">\n                              <h2 class=\"text-4xl lg:text-5xl 2xl:text-6xl font-bold\">Model d&#8217;Innovaci\u00f3<\/h2>\n                                            <p class=\"text-lg lg:text-xl 2xl:text-2xl font-bold\">Primer escoltem i despr\u00e9s innovem<\/p>\n                                            <div class=\"flex flex-col gap-6 lg:pr-24 text-md lg:text-lg 2xl:text-xl\">\n                  <p><strong>A Gebro Pharma, la innovaci\u00f3 ens impulsa a replantejar, reinventar i optimitzar medicaments<\/strong> posant els pacients i professionals sanitaris al centre d&#8217;aquest moviment imparable. Escoltem les seves necessitats i, a partir d&#8217;elles, innovem.<\/p>\n\n                <\/div>\n                          <\/div>\n                          <div class=\"col-span-full lg:col-span-5 lg:col-start-1\">\n                <p class=\"text-md lg:text-lg 2xl:text-xl font-bold\">\n                  El nostre model d&#8217;innovaci\u00f3 es fonamenta en els medicaments de valor afegit. Emprem el model VAM (Value Added Medicines) basat en els principis seg\u00fcents:\n                <\/p>\n              <\/div>\n              <div class=\"col-span-full lg:col-span-5 lg:col-end-13\">\n                <div class=\"flex flex-col gap-10 prose-p:border-b prose-p:border-cyan-600\">\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Centrat en el pacient\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Repensar\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Reinventar\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Optimitzar els medicaments\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Millorar l&#8217;acc\u00e9s al mercat\n                    <\/p>\n                                  <\/div>\n              <\/div>\n                          <div class=\"col-span-full lg:col-span-5 lg:col-start-1\">\n                <p class=\"text-md lg:text-lg 2xl:text-xl font-bold\">\n                  El valor afegit que oferim en els medicaments es manifesta especialment en aquests tres aspectes:\n                <\/p>\n              <\/div>\n              <div class=\"col-span-full lg:col-span-5 lg:col-end-13\">\n                <div class=\"flex flex-col gap-10 prose-p:border-b prose-p:border-cyan-600\">\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Reformulaci\u00f3\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Programa cl\u00ednic\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Tecnologia\n                    <\/p>\n                                  <\/div>\n              <\/div>\n                      <\/section>\n                    \n                      <section class=\"container py-6 lg:py-20\">\n                          <p class=\"text-md lg:text-lg 2xl:text-xl font-bold max-w-lg\">\n                El nostre model d&#8217;innovaci\u00f3 es centra en els elements seg\u00fcents:\n              <\/p>\n                        <img loading=\"lazy\" decoding=\"async\" width=\"2428\" height=\"998\" src=\"https:\/\/gebro.es\/app\/uploads\/2025\/02\/Ilustracio-API-Catala.png\" class=\"w-full rounded-xl mt-6\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2025\/02\/Ilustracio-API-Catala.png 2428w, https:\/\/gebro.es\/app\/uploads\/2025\/02\/Ilustracio-API-Catala-300x123.png 300w, https:\/\/gebro.es\/app\/uploads\/2025\/02\/Ilustracio-API-Catala-1024x421.png 1024w, https:\/\/gebro.es\/app\/uploads\/2025\/02\/Ilustracio-API-Catala-768x316.png 768w, https:\/\/gebro.es\/app\/uploads\/2025\/02\/Ilustracio-API-Catala-1536x631.png 1536w, https:\/\/gebro.es\/app\/uploads\/2025\/02\/Ilustracio-API-Catala-2048x842.png 2048w\" sizes=\"auto, (max-width: 2428px) 100vw, 2428px\" \/>\n          <\/section>\n                    \n                      <section class=\"container grid grid-cols-12 gap-x-8 gap-y-20 py-6 lg:py-20 \">\n            <div class=\"col-span-full lg:col-span-6 flex flex-col gap-6\">\n                              <h2 class=\"text-4xl lg:text-5xl 2xl:text-6xl font-bold\">Proposta de valor<\/h2>\n                                                          <div class=\"flex flex-col gap-6 lg:pr-24 text-md lg:text-lg 2xl:text-xl\">\n                  <p>Des del nostre <strong>Departament d&#8217;Innovaci\u00f3<\/strong> generem idees de medicaments basats en mol\u00e8cules conegudes per\u00f2 que aporten un benefici addicional a la salut dels pacients i dels seus cuidadors. Aquest valor afegit pot estar relacionat amb l&#8217;efic\u00e0cia del medicament, la seguretat, la posologia, la via d&#8217;administraci\u00f3, la formulaci\u00f3 o la combinaci\u00f3, entre d\u2019altres aspectes. Ens apassiona crear projectes d&#8217;innovaci\u00f3 propis col\u00b7laborant amb reconeguts grups de recerca p\u00fablics i privats, aix\u00ed com amb institucions del territori al m\u00e9s alt nivell. Ens centrem principalment en \u00e0rees on tenim una forta pres\u00e8ncia: malalties autoimmunes, dolor, respiratori i urologia.<\/p>\n\n                <\/div>\n                          <\/div>\n                          <div class=\"col-span-full lg:col-span-5 lg:col-start-1\">\n                <p class=\"text-md lg:text-lg 2xl:text-xl font-bold\">\n                  La nostra fortalesa a l&#8217;hora de realitzar acords es basa en aquests punts:\n                <\/p>\n              <\/div>\n              <div class=\"col-span-full lg:col-span-5 lg:col-end-13\">\n                <div class=\"flex flex-col gap-10 prose-p:border-b prose-p:border-cyan-600\">\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Agilitat en la presa de decisions i negociacions d&#8217;acords\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Coneixements en assumptes regulatoris\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      S\u00f2lida relaci\u00f3 amb les autoritats per a negociacions de preus i reemborsaments\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Disponibilitat de recursos interns per a la promoci\u00f3 i inversi\u00f3 en nous productes\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Comprom\u00eds a llarg termini amb tots els nostres productes\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Desenvolupament d&#8217;activitats comercials amb valor afegit\n                    <\/p>\n                                  <\/div>\n              <\/div>\n                      <\/section>\n                    \n            <section class=\"container py-6\">\n          <div class=\"text-md lg:text-lg 2xl:text-xl max-w-sm\">\n            <p>Tenim un <strong>model virtual d&#8217;I+D<\/strong> en qu\u00e8 l&#8217;organitzaci\u00f3 treballa amb un nombre limitat de personal intern i utilitza recursos externs, tecnologies i instal\u00b7lacions segons demanda per desenvolupar els seus projectes d&#8217;investigaci\u00f3 i desenvolupament. Aquest model ofereix nombrosos<strong> avantatges<\/strong> com ara: <strong>requisits de capital, costos generals i riscos financers redu\u00efts, costos d&#8217;infraestructura limitats<\/strong> i, per descomptat, <strong>una major flexibilitat<\/strong>.<\/p>\n\n          <\/div>\n        <\/section>\n            \n                      <section class=\"container py-6 lg:py-20\">\n                          <p class=\"text-md lg:text-lg 2xl:text-xl font-bold max-w-lg\">\n                Market pull:\n              <\/p>\n                        <img loading=\"lazy\" decoding=\"async\" width=\"1214\" height=\"260\" src=\"https:\/\/gebro.es\/app\/uploads\/2025\/02\/Market-pull-catala.png\" class=\"w-full rounded-xl mt-6\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2025\/02\/Market-pull-catala.png 1214w, https:\/\/gebro.es\/app\/uploads\/2025\/02\/Market-pull-catala-300x64.png 300w, https:\/\/gebro.es\/app\/uploads\/2025\/02\/Market-pull-catala-1024x219.png 1024w, https:\/\/gebro.es\/app\/uploads\/2025\/02\/Market-pull-catala-768x164.png 768w\" sizes=\"auto, (max-width: 1214px) 100vw, 1214px\" \/>\n          <\/section>\n                \n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-business.blade.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1528","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Business Development &amp; innovaci\u00f3 - Gebro Pharma<\/title>\n<meta name=\"description\" content=\"Buscamos activamente sinergias para impulsar la innovaci\u00f3n mediante colaboraci\u00f3n con partners y acuerdos de licensing in &amp; out.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Business Development &amp; innovaci\u00f3 - Gebro Pharma\" \/>\n<meta property=\"og:description\" content=\"Buscamos activamente sinergias para impulsar la innovaci\u00f3n mediante colaboraci\u00f3n con partners y acuerdos de licensing in &amp; out.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/\" \/>\n<meta property=\"og:site_name\" content=\"Gebro Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-25T13:43:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/gebro.es\\\/ca\\\/business-development-i-innovacio\\\/\",\"url\":\"https:\\\/\\\/gebro.es\\\/ca\\\/business-development-i-innovacio\\\/\",\"name\":\"Business Development &amp; innovaci\u00f3 - Gebro Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/ca\\\/#website\"},\"datePublished\":\"2023-12-13T09:45:33+00:00\",\"dateModified\":\"2026-02-25T13:43:26+00:00\",\"description\":\"Buscamos activamente sinergias para impulsar la innovaci\u00f3n mediante colaboraci\u00f3n con partners y acuerdos de licensing in & out.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/ca\\\/business-development-i-innovacio\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/gebro.es\\\/ca\\\/business-development-i-innovacio\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/gebro.es\\\/ca\\\/business-development-i-innovacio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\",\"item\":\"https:\\\/\\\/gebro.es\\\/ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Business Development &amp; innovaci\u00f3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/gebro.es\\\/ca\\\/#website\",\"url\":\"https:\\\/\\\/gebro.es\\\/ca\\\/\",\"name\":\"Gebro Pharma\",\"description\":\"At Gebro Pharma we improve your health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/gebro.es\\\/ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Business Development &amp; innovaci\u00f3 - Gebro Pharma","description":"Buscamos activamente sinergias para impulsar la innovaci\u00f3n mediante colaboraci\u00f3n con partners y acuerdos de licensing in & out.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/","og_locale":"ca_ES","og_type":"article","og_title":"Business Development &amp; innovaci\u00f3 - Gebro Pharma","og_description":"Buscamos activamente sinergias para impulsar la innovaci\u00f3n mediante colaboraci\u00f3n con partners y acuerdos de licensing in & out.","og_url":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/","og_site_name":"Gebro Pharma","article_modified_time":"2026-02-25T13:43:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/","url":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/","name":"Business Development &amp; innovaci\u00f3 - Gebro Pharma","isPartOf":{"@id":"https:\/\/gebro.es\/ca\/#website"},"datePublished":"2023-12-13T09:45:33+00:00","dateModified":"2026-02-25T13:43:26+00:00","description":"Buscamos activamente sinergias para impulsar la innovaci\u00f3n mediante colaboraci\u00f3n con partners y acuerdos de licensing in & out.","breadcrumb":{"@id":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gebro.es\/ca\/business-development-i-innovacio\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"","item":"https:\/\/gebro.es\/ca\/"},{"@type":"ListItem","position":2,"name":"Business Development &amp; innovaci\u00f3"}]},{"@type":"WebSite","@id":"https:\/\/gebro.es\/ca\/#website","url":"https:\/\/gebro.es\/ca\/","name":"Gebro Pharma","description":"At Gebro Pharma we improve your health","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gebro.es\/ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"}]}},"_links":{"self":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/pages\/1528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/comments?post=1528"}],"version-history":[{"count":5,"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/pages\/1528\/revisions"}],"predecessor-version":[{"id":1934,"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/pages\/1528\/revisions\/1934"}],"wp:attachment":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/media?parent=1528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}